Metoclopramide attenuates iminodipropionitrile-induced oxidative stress and neurobehavioral toxicity in rats

Pharmacology Biochemistry and Behavior

Volumn 79, Issue 3, 2004, Pages 555-561

  Ahmad Khan, Haseeb ^a   Al Deeb, Saleh ^a   Al Moutaery, Khalaf ^a   Tariq, Mohammad ^a  

^a Prince Sultan Military Medical City   (Saudi Arabia)

Author keywords

Drug induced dyskinesia; Free radicals; Neurotransmitters; Oxidative stress

Indexed keywords

3,3' IMINODIPROPIONITRILE; ANTIEMETIC AGENT; FREE RADICAL; METOCLOPRAMIDE;

ARTICLE; BEHAVIOR; CHEMICAL ANALYSIS; CHOREA; CIRCLING BEHAVIOR; DOSE RESPONSE; DYSKINESIA; EXCITATION; FEMALE; GRIP STRENGTH; HEAD MOVEMENT; MEASUREMENT; MOTOR DYSFUNCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT STRAIN; RIGHTING REFLEX;

ANIMALS; FEMALE; METOCLOPRAMIDE; MOTOR ACTIVITY; MOVEMENT DISORDERS; NITRILES; OXIDATIVE STRESS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS NORVEGICUS; RODENTIA;

EID: 9644274268     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.09.006     Document Type: Article

References (73)

1. A.E. Ahmed, and N.M. Trieff Aliphatic nitriles: metabolism and toxicity J.W. Bridges L.F. Chasseaud Progress in drug metabolism vol. 7 1983 Wiley New York (USA) 229 294
2. S. Al Deeb, K. Al Moutaery, H.A. Khan, and M. Tariq Exacerbation of iminodipropionitrile-induced behavioral toxicity, oxidative stress, and vestibular hair cell degeneration by gentamycin in rats Neurotoxicol. Teratol. 22 2000 213 220
3. D.I. Axon, G.H. Fletcher, and M.S. Starr In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking Pharmacol. Biochem. Behav. 26 1987 45 47
4. E. Bergmark Hemoglobin adducts of acrylamide and acrylonitirle in laboratory workers, smokers and nonsmokers Chem. Res. Toxicol. 10 1997 78 84
5. S. Cabib, C. Castellano, V. Cestari, U. Filibeck, and S. Puglisi-Allegra D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse Psychopharmacology 105 1991 335 339
6. J.L. Cadet, T. Braun, and W.J. Freed The dopamine D2 antagonist-Ro22- 1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile in mice Exp. Neurol. 96 1987 594 600
7. 2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesia induced by iminodipropionitrile (IDPN): evidence from autoradiographic studies Brain Res. 437 1987 383 386
8. A. Chagraoui, M. Vasse, and P. Protais Interaction of amineptine with agents modifying dopaminergic transmission Clin. Neuropharmacol. 12 Suppl. 2 1989 S19 S31
9. W.H. Chang, T.Y. Chen, H.S. Wu, W.H. Hu, and E.K. Yeh Dose-response curves of homovanillic acid in pre-frontal cortex and caudate following antipsychotic drugs: relation to clinical potencies Psychopharmacology 95 1988 459 462
10. G.C. Chiou, and B.H. Li Effects of dopamine antagonists on retinal B-wave recovery after retinal ischemia J. Ocul. Pharmacol. 9 1993 179 185
11. R. Dall'Olio, A. Vaccheri, O. Gandolfi, P. Roncada, and N. Montanaro Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats Pharmacol. Biochem. Behav. 31 1988 941 944
12. R. Dawson Jr., E.G. Marschall, K.C. Chan, W.J. Millard, B. Eppler, and T.A. Patterson Neurochemical and neurobehavioral effects of neonatal administration of beta-N-methylamino-l-alanine and 3,3′- iminodipropionitrile Neurotoxicol. Teratol. 20 1998 181 192
13. J. Delay, P. Pichot, J. Thuillier, and J.P. Marquiset Action de l'amino-dipropionitrile sur le comportement moteur de la souris blanche C. R. Soc. Biol. 146 1952 533 534
14. Z. Desta, G.M. Wu, A.M. Morocho, and D.A. Flockhart The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6 Drug Metab. Dispos. 30 2002 336 343
15. D.T. Dexter, R.J. Ward, F.R. Wells, S.E. Daniel, A.J. Lees, and T.J. Peters α-Tocopherol levels in brain are not altered in Parkinson's disease Ann. Neurol. 32 1992 591 593
16. B.I. Diamond, K. Sethi, and R.C. Borison Serotonin modulation of hyperkinesias and phasic neck dystonia induced by iminodipropionitrile (IDPN) in rats Neurology 36 Suppl. 1 1986 341
17. K.L. Drew, and S.D. Glick Role of D1 and D2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response Psychopharmacology 101 1990 465 471
18. M.G. Fiori, L.R. Sharer, and H.E. Lowndes Communicating hydrocephalus in rodents treated with beta,beta′-iminodipropionitrile (IDPN) Acta Neuropathol. (Berl.) 65 3-4 1985 209 216
19. R. Frussa-Filho, and J. Palermo-Neto Effects of single and long-term metoclopramide administration on open field and stereotyped behavior of rats Eur. J. Pharmacol. 149 1988 323 329
20. F. Gagnaire, B. Marignac, and P. Bonnet Relative neurotoxicological properties of five unsaturated aliphatic nitriles in rats J. Appl. Toxicol. 18 1998 25 31
21. L. Ganzini, R.T. Heintz, W.F. Hoffman, G. Keepers, and D.E. Casey Acute extrapyramidal syndromes in neuroleptic-treated elderly: a pilot study J. Geriatr. Psychiatry Neurol. 4 1991 222 226
22. L. Ganzini, D.E. Casey, W.F. Hoffman, and A.L. McCall The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders Arch. Int. Med. 153 1993 1469 1475
23. H.M. Gao, J.S. Hong, W. Zhang, and B. Liu Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide; relevance to the etiology of Parkinson's disease J. Neurosci. 23 4 2003 1228 1236
24. G. Gianutsos, and P.D. Suzdak Neurochemical effects of IDPN on the mouse brain Neurotoxicology 6 1985 159 164
25. P. Gil-Loyzaga, M.A. Vicente-Torres, M. Garcia-Bonacho, and A. Esquifino Presence of catecholamines and serotonin in the rat vestibule Brain Res. 746 1997 625 628
26. A.R. Green 5-HT mediated behavior Neuropharmacology 23 1984 1521 1528
27. S.S. Guirguis, M.B. Cohen, and G.S. Rajhans A review of health risks in acrylonitrile industry G. Ital. Med. Lav. 6 1984 87 93
28. G.J. Handelman, W.L. Epstein, L.J. Macklin, J.G.M. Van Kujik, and E.A. Dratz Biopsy method for human adipose with vitamin E and lipid measurements Lipids 23 1988 598 604
29. M.N. Hassan, A. Raches, C. Kuhn, D. Higgins, and S. Fahn Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide Clin. Neuropharmacol. 9 1986 71 78
30. Z.S. Herman, and M. Huzarska Chronic treatment with atypical neuroleptics sulpiride and metoclopramide increases striatal enkephalins in rat brain Pol. J. Pharmacol. 45 1993 402 493
31. K. Hozawa, and T. Takasak Catecholaminergic innervation in the vestibular labyrinth and vestibular nucleus of guinea pigs Acta Otorrinolaringol., Suppl. 503 1993 111 113
32. K. Iida, E. Wata, M. Asanuma, S.N. Asanuma, M. Gomez-Vargas, and I. Miyazaki Effects of repeated cyclosporin A administration on iminodipropionitrile-induced dyskinesia and TRE-/CRE-binding activities in rat brain Neurosci. Res. 30 1998 185 193
33. D. Jarrar, P. Wang, G.Y. Song, M.W. Knoferl, W.G. Cioffi, and K.I. Bland Metoclopramide: a novel adjunct for improving cardiac and hepatocellular functions after trauma-hemorrhage Am. J. Physiol.: Endocrinol. Metab. 278 2000 E90 E95
34. I. Jeding, P.J. Evans, D. Akanmu, D. Dexter, J.D. Spencer, and O.I. Aruoma Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs Biochem. Pharmacol. 49 1995 359 365
35. H.A. Khan, S. Al Deeb, K. Al Moutaery, and M. Tariq Influence of age on iminodipropionitrile-induced vestibular and neurobehavioral toxicities in rats Exp. Toxicol. Pathol. 55 2003 181 186
36. P.J. Langlais, and S. Gabay Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin J. Neurosci. Res. 3 1977 135 141
37. Y. Li, H. Matsuda, J. Yamahara, and M. Yoshikawa Acceleration of gastrointestinal transit by momordin Ic in mice: possible involvement of 5-hydroxytryptamine, 5-HT (2) receptors and prostaglandins Eur. J. Pharmacol. 392 2000 71 77
38. J. Llorens, and K.M. Crofton Enhanced neurotoxicity of 3,3′-iminodipropionitrile following carbon tetrachloride pretreatment in the rat Neurotoxicology 12 3 1991 583 594
39. J. Llorens, D. Dememes, and A. Sans The behavioral syndrome caused by 3,3′-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells Toxicol. Appl. Pharmacol. 123 1993 199 210
40. J. Llorens, K.M. Crofton, and J.P. O'Callaghan Administration of 3,3′-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem J. Pharmacol. Exp. Ther. 265 1993 1492 1498
41. J. Llorens, D. Dememes, and A. Sans The toxicity of IDPN on the vestibular system of the rat: new insights on its effects on behavioral and neurofilament transport Neurotoxicology 15 1994 643 648
42. J.B. Lohr, L.C. Cadet, and RJ. Wyatt Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by α-tocopherol (vitamin E) Neuropsychopharmacology 1 1988 305 309
43. L.J. May, and RM. Wightman Effects of D-2 antagonists on frequency-dependent stimulated dopamine overflow in nucleus accumbens and caudate-putamen J. Neurochem. 53 1989 606 898
44. D.B. Miller, J.F. Reinhard Jr., A.J. Daniels, and J.P. O'Callaghan Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium J. Neurochem. 57 2 1991 541 549
45. A.G. Molloy, K.M. O'Boyle, M.T. Pugh, and T.L. Waddington Locomotor behaviors in response to new selective D1 and D2 dopamine receptor agonists and the influence of selective antagonists Pharmacol. Biochem. Behav. 25 1986 249 253
46. V.C. Moser, and W.K. Boyes Prolonged neurobehavioral and visual effects of short-term exposure to 3,3′-iminodipropionitrile (IDPN) in rats Fundam. Appl. Toxicol. 21 1993 277 290
47. C.G. Nace, M.B. Genter, L.M. Sayre, and K.M. Crofton Effect of methimazole, an FMO substrate and competitive inhibitor on the neurotoxicity of 3,3′-iminodipropionitrile in male rats Fundam. Appl. Toxicol. 37 1997 131 140
48. J. Noraberg, and P. Arlien-Soborg Neurotoxic interactions of industrially used ketones Neurotoxicology 21 3 2000 409 418
49. N. Ogawa, K. Haba, M. Asanuma, and A. Mori Long-lasting effect of ceruletide on dyskinesia and monoaminergic neuronal pathways in rats treated with iminodipropionitrile Brain Res. 556 1991 271 279
50. C.W. Olanow Introduction to the free radical hypothesis in Parkinson's disease Ann. Neurol. 32 1992 52 59
51. L. Perbellini, A. Ganzi, G. Venturi, M. Cerpelloni, and F. Brugnone Biological monitoring of acrylonitrile exposure G. Ital. Med. Lav. Ergonom. 20 1998 10 14
52. A. Plaznik, R. Stefanski, and W. Kostowski Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity Psychopharmacology 99 1989 558 562
53. A. Robertson, and C. MacDonald Opposite effects of sulpiside and metoclopramide on amphetamine-induced stereotypy Eur. J. Pharmacol. 109 1985 81 89
54. C. Scarpignato Pharmacological stimulation of gastrointestinal motility: where we are and where are we going? Dig. Dis. 15 1997 112 136
55. G. Schneider, H. Oepen, and A. Klapproth On age-dependent effects of IDPN in the rat ZFA 35 3 1980 231 237
56. B. Scolnick, D. Hamel, and A.D. Woolf Successful treatment of life-threatening propionitrile exposure with sodium nitrite/sodium thosulfate followed by hyperbaric oxygen J. Occup. Med. 35 1993 577 580
57. H. Selye Lathyrism Rev. Can. Biol. 16 1957 1 2
58. D.D. Sewell, A.B. Kodsi, M.P. Caliguiri, and D.V. Jeste Metoclopramide and tardive dyskinesia Biol. Psychiatry 36 1994 630 632
59. H. Sies Oxidative stress 1985 Academic Press New York
60. P.S. Spencer, and H.H. Schaumburg Lathyrism: a neurotoxic disease Neurobehav. Toxicol. Teratol. 5 1983 625 629
61. 2 concentration in PC12h cells: effects of tachykinin peptides Neurosci. Lett. 246 1998 141 144
62. Y. Tang, K.C. Donnelly, E. Tiffany-Castiglioni, and M.M. Mumtaz Neurotoxicity of polycyclic aromatic hydrocarbons and simple chemical mixtures J. Toxicol. Environ. Health 66 10 2003 919 940
63. H. Tanii, M. Hayashi, and K. Hashimoto Nitrile-induced behavioral abnormalities in mice Neurotoxicology 10 1989 157 166
64. H. Tanii, M. Hayashi, and K. Hashimoto Behavioral syndrome induced by allylnitrile, crotonitrile or 2-pentenenitrile in rats Neuropharmacology 90 1991 887 892
65. M. Tariq, S. Al Deeb, K. Al Moutaery, G.W. Bruyn, D. Price Evans, and M. Arshaduddin Dipyridamole attenuates the development of iminodipropionitrile- induced dyskinetic abnormalities in rats Brain Res. Bull. 38 1995 31 35
66. M. Tariq, S. Al Deeb, K. Al Moutaery, S. Mujeebuddin, M. Arshaduddin, and G.W. Bruyn Effect of selenium and vitamin E on iminodipropionitrile-induced dyskinesia in rats Int. J. Neurosci. 78 1995 185 192
67. M. Tariq, H.A. Khan, Z. Rehana, K. Al Moutaery, and S. Al Deeb Proglumide, a cholecystokinin receptor antagonist, exacerbates β′β′-iminodipropionitrile-induced dyskinetic syndrome in rats Neurotoxicol. Teratol. 20 1998 571 579
68. M. Tariq, H.A. Khan, K. Al Moutaery, and S. Al Deeb Attenuation of iminodipropionitrile induced behavioral syndrome by sodium salicylate in rats Pharmacol. Biochem. Behav. 73 2002 647 654
69. S.A.B. Van Acer, L.M.H. Koymans, and A. Bart Molecular pharmacology of vitamin E: structural aspects of antioxidant activity Free Radic. Biol. Med. 15 1993 311 328
70. N. Wakata, Y. Araki, H. Sugimoto, H. Iguchi, and M. Kinoshita IDPN-induced monoamine and hydroxyl radical changes in the rat brain Neurochem. Res. 25 2000 401 404
71. N.V. Watson, E.L. Hargreaves, D. Penava, L.A. Eckel, and C.H. Vanderwolf Serotonin-dependent cerebral activation: effects of methiothepin and other serotonergic antagonists Brain Res. 597 1992 16 23
72. D. Wirtshafter, and K.E. Asin Dopamine antagonists induce fos-like-immunoreactivity in the substantia nigra and entopeduncular nucleus of the rat Brain Res. 670 1995 205 214
73. R. Zellweger, M.W. Wichmann, A. Ayala, and I.H. Chaudry Metoclopramide: a novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhage J. Trauma 44 1998 70 76